Investigator Initiated Depuy Replacement knee In-Vivo Evaluation Study

ISRCTN ISRCTN26541777
DOI https://doi.org/10.1186/ISRCTN26541777
Secondary identifying numbers Version 1.1
Submission date
12/08/2010
Registration date
08/10/2010
Last edited
04/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Anthony Redmond
Scientific

Leeds Institute for Molecular Medicine
Section of Musculoskeletal Disease
2nd Floor, Chapel Allerton Hospital
Harehills Lane
Leeds
LS7 4SA
United Kingdom

Study information

Study designPost-operative comparator randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleInvestigator Initiated Depuy Replacement knee In-Vivo Evaluation Study: a post-operative comparator study characterising the in-vivo functional capacities of patients following total knee arthroplasty (TKA) after randomisation to one of two different implant types
Study acronymDRIVE
Study objectivesTo compare the in-vivo function of the PFC sigma cruciate retaining (CR) implant with the PFC CR 150 at 3, 6 and 12 months post-operatively.
Ethics approval(s)Leeds West Research Ethics Committee, 01/02/2010, ref: 09/H1307/103
Health condition(s) or problem(s) studiedOsteoarthritis
InterventionA total of 40 patients will be recruited to the study. These patients will undergo a range of baseline evaluations as appropriate to their presenting condition. These would include:
1. A routine musculoskeletal clinical examination (including assessment of presenting symptoms and clinical musculoskeletal functional tests)
2. Completion of relevant patient reported outcome instruments (36-item short form health survey [SF-36], Oxford knee score, Knee Injury and Osteoarthritis Outcome Score [KOOS], Knee Society Clinical Rating System [KSS])
3. Knee joint kinematics and kinetics measured using Vicon T series, Oxford Metrics Oxford UK
4. Functional measures to be undertaken include:
4.1. High flexion angle joint function measured using Fastrak electromagnetic motion tracking (Polhemus, USA)
4.2. High demand joint function (Sit to stand and squat) measured using Vicon T series (Oxford Metrics Oxford, UK)

A case/control design will be used to compare outcomes following surgery in patients receiving PFC sigma and CR150 implants. Patients will undergo the same range of evaluations as those described above at 3 months, 6 months and 1 year.
Intervention typeOther
Primary outcome measureMaximum knee flexion measured using the Fastrak electromagnetic motion tracking system (Polhemus, USA)
Secondary outcome measuresA comparison of high performance activities (sit to stand and squatting) 12 months after surgery
Overall study start date01/11/2010
Completion date30/09/2012

Eligibility

Participant type(s)Patient
Age groupAll
SexBoth
Target number of participants40
Key inclusion criteria1. Patients (no age limit, either sex) with osteoarthritis of the knee undergoing unilateral knee replacement at Chapel Allerton Orthopaedic Centre
2. Patients with a functionally normal contralateral knee
Key exclusion criteria1. Patients who cannot safely walk unaided
2. Patients who decline to give permission for their clinical data to be used in anonymised form for research purposes
3. Patients who are unable to give informed consent
Date of first enrolment01/11/2010
Date of final enrolment30/09/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Leeds Institute for Molecular Medicine
Leeds
LS7 4SA
United Kingdom

Sponsor information

University of Leeds (UK)
University/education

Woodhouse Lane
Leeds
LS2 9JT
England
United Kingdom

Website http://www.leeds.ac.uk/
ROR logo "ROR" https://ror.org/024mrxd33

Funders

Funder type

Industry

DePuy International Limited (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

04/10/2017: No publications found in PubMed, verifying study status with principal investigator.